Advanced Drug Delivery Systems Global Market Opportunities And Strategies To 2033

Description

Advanced drug delivery systems (ADDS) refer to innovative and sophisticated techniques or technologies designed to enhance the delivery of therapeutic agents (drugs) to specific target sites in the body. ADDS encompass a broad range of approaches, including formulations, carriers and strategies that aim to improve the efficacy, safety and patient compliance of drug delivery.

The advanced drug delivery systems market consists of sales, by entities (organizations, partnerships and sole proprietors), of advanced drug delivery systems that include technologies and methodologies to deliver drugs to specific parts of the body in a controlled manner.

The global advanced drug delivery systems market was valued at $192,214.2 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.0%.

Growing Use Of Telemedicine Services

The growing use of telemedicine services supported the growth of the advanced drug delivery systems market during the historic period. Telemedicine is a type of healthcare that involves the use of technology, namely telecommunication equipment and digital platforms, to provide healthcare advice, evaluation, therapy and follow-up to patients remotely. Incorporating drug delivery systems with telemedicine facilitates simple and efficient healthcare delivery, assuring patients receive appropriate drugs, support and advice, even if they are geographically separated from healthcare practitioners or facilities. According to the Australian Digital Health Agency, an Australia-based government organization in charge of digital prescriptions, medical referral networks and My Health Record, 118.2 million telehealth therapy services were offered to 18 million people between March 2020 and July 2022, and more than 95,000 practitioners employ telehealth services. Therefore, the growing use of telemedicine services supported the growth of the advanced drug delivery systems market.

Introducing Preclinical Drug Development With Advanced Drug Delivery Technology

Companies are introducing preclinical drug development with advanced drug delivery technology (EUDRACAP) to accelerate innovation, unlock value and improve quality in the preclinical development stage. This is used to enhance preclinical drug development by offering functional, ready-to-fill oral capsules. These capsules simplify the drug development process, reduce time and variables and safeguard the active ingredient to optimize absorption rates and prevent premature degradation. For example, in October 2023, Evonik, a German-based specialty chemicals company, launched an advanced drug delivery system, called EUDRACAP preclinic enteric, a functional oral capsule designed for use in preclinical trials. This capsule is a very small, 9-h (5.1 mm) technical-grade capsule, suitable for passing through the gastrointestinal tract of preclinical subjects. The capsule simplifies drug development by reducing time, cost and variables and leverages EUDRAGIT(R) functional coatings for optimized release profiles, while offering custom options for specific active pharmaceutical ingredient (API), formulation and brand requirements and a seamless transition from preclinical to clinical and commercial stages, with support for custom capsule coatings, formulation development and current good manufacturing practice (cGMP) scale-up.

The global advanced drug delivery systems market is highly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 2.91% of the total market in 2022.

Advanced Drug Delivery Systems Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global advanced drug delivery systems market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies based on local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for advanced drug delivery systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The advanced drug delivery systems market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider advanced drug delivery systems market; and compares it with other markets.

The report covers the following chapters:

Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by carrier type, by technology, by application and by end user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the advanced drug delivery systems market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by carrier type, by technology, by application and by end user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size And Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations - This section includes recommendations for advanced drug delivery systems providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Type: Oral Drug Delivery System; Injection-Based Drug Delivery System; Inhalation/Pulmonary Drug Delivery System; Transdermal Drug Delivery System; Transmucosal Drug Delivery System; Carrier-Based Drug Delivery System And Other Types
2) By Carrier Type: Liposomes; Nanoparticles; Microspheres; Monoclonal Antibodies; Other Carrier Types
3) By Technology: Prodrug; Implants And Intrauterine Devices; Targeted Drug Delivery; Polymeric Drug Delivery; Other Technologies
4) By Application: Oncology; Anti-Infective; Central Nervous System; Respiratory Diseases; Cardiovascular Diseases; Musculoskeletal Disorders; Metabolic Disorders; Other Applications
5) 4) By End User: Hospitals; Specialized Clinics; Other End Users
Companies Mentioned: Johnson & Johnson, Inc; Baxter; Becton, Dickinson And Company; Medtronic Plc; Pacira Biosciences, Inc
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; advanced drug delivery systems indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1094

1 Executive Summary

1.1 Advanced Drug Delivery Systems - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Advanced Drug Delivery Systems Market Definition And Segmentations
6.4 Market Segmentation By Type
- 6.4.1 Oral Drug Delivery System
- 6.4.2 Injection-Based Drug Delivery System
- 6.4.3 Inhalation/Pulmonary Drug Delivery System
- 6.4.4 Transdermal Drug Delivery System
- 6.4.5 Transmucosal Drug Delivery System
- 6.4.6 Carrier-Based Drug Delivery System
- 6.4.7 Other Types
6.5 Market Segmentation By Carrier Type
- 6.5.1 Liposomes
- 6.5.2 Nanoparticles
- 6.5.3 Microspheres
- 6.5.4 Monoclonal Antibodies
- 6.5.5 Other Carrier Types
6.6 Market Segmentation By Technology
- 6.6.1 Prodrug
- 6.6.2 Implants And Intrauterine Devices
- 6.6.3 Targeted Drug Delivery
- 6.6.4 Polymeric Drug Delivery
- 6.6.5 Other Technologies
6.7 Market Segmentation By Application
- 6.7.1 Oncology
- 6.7.2 Anti-Infective
- 6.7.3 Central Nervous System
- 6.7.4 Respiratory Diseases
- 6.7.5 Cardiovascular Diseases
- 6.7.6 Musculoskeletal Disorders
- 6.7.7 Metabolic Disorders
- 6.7.8 Other Application
6.8 Market Segmentation By End User
- 6.8.1 Hospitals
- 6.8.2 Specialized Clinics
- 6.8.3 Other End Users

7 Major Market Trends

7.1 Introducing Preclinical Drug Development With Advanced Drug Delivery Technology
7.2 Increasing Focus Dissolving Microneedle Drug Delivery Methods
7.3 Innovative On-Body Delivery Systems For Subcutaneous Therapies
7.4 Pioneering Advanced Drug Delivery With Thin Film Formulation
7.5 Strategic Partnerships And collaborations Among Market Players To Drive Innovation and Expansion In The Market

8 Advanced Drug Delivery Systems Market - Macro Economic Scenario

8.1 COVID-19 Impact On The Advanced Drug Delivery Systems Market
8.2 Impact Of The War In Ukraine On The Advanced Drug Delivery Systems Market
8.3 Impact Of High Inflation On The Advanced Drug Delivery Systems Market

9 Global Market Size and Growth

9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
- 9.2.1 Market Drivers 2018 - 2023
- 9.2.2 Market Restraints 2018 - 2023
9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
- 9.3.1 Market Drivers 2023 - 2028
- 9.3.2 Market Restraints 2023 - 2028

10 Global Advanced Drug Delivery Systems Market Segmentation

10.1 Global Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.4 Global Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.5 Global Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Advanced Drug Delivery Systems Market, Regional and Country Analysis

11.1 Global Advanced Drug Delivery Systems Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Advanced Drug Delivery Systems Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

12.1 Summary
- 12.1.1 Market Overview
- 12.1.2 Region Information
- 12.1.3 Market Information
- 12.1.4 Background Information
- 12.1.5 Government Initiatives
- 12.1.6 Regulations
- 12.1.7 Regulatory Bodies
- 12.1.8 Major Associations
- 12.1.9 Taxes Levied
- 12.1.10 Corporate Tax Structure
- 12.1.11 Investments
- 12.1.12 Major Companies
12.2 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Advanced Drug Delivery Systems Market: Country Analysis
12.6 China Market
12.7 Summary
- 12.7.1 Market Overview
- 12.7.2 Country Information
- 12.7.3 Market Information
- 12.7.4 Background Information
- 12.7.5 Government Initiatives
- 12.7.6 Regulations
- 12.7.7 Regulatory Bodies
- 12.7.8 Major Associations
- 12.7.9 Taxes Levied
- 12.7.10 Corporate Tax Structure
- 12.7.11 Investments
- 12.7.12 Major Companies
12.8 China Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.9 China Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 China Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.14 India Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.20 Australia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.22 Australia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

13.1 Summary
- 13.1.1 Market Overview
- 13.1.2 Region Information
- 13.1.3 Market Information
- 13.1.4 Background Information
- 13.1.5 Government Initiatives
- 13.1.6 Regulations
- 13.1.7 Regulatory Bodies
- 13.1.8 Major Associations
- 13.1.9 Taxes Levied
- 13.1.10 Corporate Tax Structure
- 13.1.11 Investments
- 13.1.12 Major Companies
13.1 Western Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.2 Western Europe Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Advanced Drug Delivery Systems Market: Country Analysis
13.5 UK Market
13.6 UK Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.7 UK Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.8 UK Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 Germany Market
13.10 Germany Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.11 Germany Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.13 France Market
13.14 France Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.15 France Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.16 France Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 Italy Market
13.18 Italy Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.19 Italy Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.20 Italy Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 Spain Market
13.22 Spain Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.23 Spain Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.24 Spain Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

14.1 Summary
- 14.1.1 Market Overview
- 14.1.2 Region Information
- 14.1.3 Market Information
- 14.1.4 Background Information
- 14.1.5 Government Initiatives
- 14.1.6 Regulations
- 14.1.7 Regulatory Bodies
- 14.1.8 Major Associations
- 14.1.9 Taxes Levied
- 14.1.10 Corporate Tax Structure
- 14.1.11 Investments
- 14.1.12 Major Companies
14.2 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Advanced Drug Delivery Systems Market: Country Analysis
14.6 Russia Market
14.7 Russia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.8 Russia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

15.1 Summary
- 15.1.1 Market Overview
- 15.1.2 Region Information
- 15.1.3 Market Information
- 15.1.4 Background Information
- 15.1.5 Government Initiatives
- 15.1.6 Regulations
- 15.1.7 Regulatory Bodies
- 15.1.8 Major Associations
- 15.1.9 Taxes Levied
- 15.1.10 Corporate Tax Structure
- 15.1.11 Investments
- 15.1.12 Major Companies
15.2 North America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.3 North America Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Advanced Drug Delivery Systems Market: Country Analysis
15.6 USA Market
15.7 Summary
- 15.7.1 Market Overview
- 15.7.2 Country Information
- 15.7.3 Market Information
- 15.7.4 Background Information
- 15.7.5 Government Initiatives
- 15.7.6 Regulations
- 15.7.7 Regulatory Bodies
- 15.7.8 Major Associations
- 15.7.9 Taxes Levied
- 15.7.10 Corporate Tax Structure
- 15.7.11 Investments
- 15.7.12 Major Companies
15.8 USA Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.9 USA Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.10 USA Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 Canada Market
15.12 Canada Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.14 Canada Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

16.1 Summary
- 16.1.1 Market Overview
- 16.1.2 Region Information
- 16.1.3 Market Information
- 16.1.4 Background Information
- 16.1.5 Government Initiatives
- 16.1.6 Regulations
- 16.1.7 Regulatory Bodies
- 16.1.8 Major Associations
- 16.1.9 Taxes Levied
- 16.1.10 Corporate Tax Structure
- 16.1.11 Investments
- 16.1.12 Major Companies
16.2 South America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.3 South America Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Advanced Drug Delivery Systems Market: Country Analysis
16.6 Brazil Market
16.7 Brazil Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

17.1 Summary
- 17.1.1 Market Overview
- 17.1.2 Region Information
- 17.1.3 Market Information
- 17.1.4 Background Information
- 17.1.5 Government Initiatives
- 17.1.6 Regulations
- 17.1.7 Regulatory Bodies
- 17.1.8 Major Associations
- 17.1.9 Taxes Levied
- 17.1.10 Corporate Tax Structure
- 17.1.11 Investments
- 17.1.12 Major Companies
17.2 Middle East Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

18.1 Summary
- 18.1.1 Market Overview
- 18.1.2 Region Information
- 18.1.3 Market Information
- 18.1.4 Background Information
- 18.1.5 Government Initiatives
- 18.1.6 Regulations
- 18.1.7 Regulatory Bodies
- 18.1.8 Major Associations
- 18.1.9 Taxes Levied
- 18.1.10 Corporate Tax Structure
- 18.1.11 Investments
- 18.1.12 Major Companies
18.2 Africa Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.3 Africa Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape and Company Profiles

19.1 Company Profile
19.2 Johnson & Johnson
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial overview
19.3 Baxter
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Business Strategy
- 19.3.4 Financial Overview
19.4 Becton, Dickinson and Company
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Overview
19.5 Medtronic Plc
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Business Strategy
- 19.5.4 Financial Overview
19.6 Pacira BioSciences, Inc.
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Financial Overview

20 Advanced Drug Delivery Systems Market Other Major And Innovative Companies

20.1 Abbvie, Inc.
- 20.1.1 Company Overview
- 20.1.2 Products And Services
- 20.1.3 Business Strategy
20.2 Gilead Sciences, Inc.
- 20.2.1 Company Overview
- 20.2.2 Products And Services
- 20.2.3 Business Strategy
20.3 Merck KGaA
- 20.3.1 Company Overview
- 20.3.2 Products And Services
- 20.3.3 Business Strategy
20.4 Danaher Corporation
- 20.4.1 Company Overview
- 20.4.2 Products And Services
20.5 Bausch Health Companies Inc
- 20.5.1 Company Overview
- 20.5.2 Products And Services
- 20.5.3 Business Strategy
20.6 Evonik Industries AG
- 20.6.1 Company Overview
- 20.6.2 Products And Services
- 20.6.3 Business Strategy
20.7 Ypsomed Holding AG
- 20.7.1 Company Overview
- 20.7.2 Products And Services
- 20.7.3 Business Strategy
20.8 SHL Medical AG
- 20.8.1 Company Overview
- 20.8.2 Products And Services
- 20.8.3 Business Strategy
20.9 West Pharmaceutical Services, Inc
- 20.9.1 Company Overview
- 20.9.2 Products And Services
- 20.9.3 Business Strategy
20.10 Novo Nordisk A/S
- 20.10.1 Company Overview
- 20.10.2 Products And Services
- 20.10.3 Business Strategy
20.11 Purdue Pharma LP
- 20.11.1 Company Overview
- 20.11.2 Products And Services
20.12 Luye Pharma Group Ltd.
- 20.12.1 Company Overview
- 20.12.2 Products And Services
20.13 Ipsen Biopharmaceuticals, Inc
- 20.13.1 Company Overview
- 20.13.2 Products And Services
- 20.13.3 Business Strategy
20.14 Sun Pharmaceutical Inc
- 20.14.1 Company Overview
- 20.14.2 Products And Services
- 20.14.3 Business Strategy
20.15 Takeda Pharmaceutical Company Limited
- 20.15.1 Company Overview
- 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

23.1 Cordis Corporation Acquired MedAlliance SA
23.2 DifGen Pharmaceuticals Acquired Aveva Drug Delivery Services Inc
23.3 LTS Lohmann Therapie-Systeme Acquired Sorrel Wearable Injection Device Business From Eitan Medical
23.4 SHL Medical Acquired LCA Automation AG
23.5 Halozyme Therapeutics Inc Acquired Antares Pharma Inc
23.6 Nemera Acquired Copernicus

24 Opportunities And Strategies

24.1 Global Advanced Drug Delivery Systems Market In 2028 - Countries Offering Most New Opportunities
24.2 Global Advanced Drug Delivery Systems Market In 2028 - Segments Offering Most New Opportunities
24.3 Global Advanced Drug Delivery Systems Market In 2028 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Advanced Drug Delivery Systems Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer